பிரபஞ்சம் மருந்துகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பிரபஞ்சம் மருந்துகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பிரபஞ்சம் மருந்துகள் Today - Breaking & Trending Today

Cassiopea Announces Results for First Half of 2021


Cassiopea Announces Results for First Half of 2021
Cassiopea S.p.A. / Key word(s): Half Year Results
29-Jul-2021 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Ad hoc announcement pursuant to Art. 53 LR
Lainate, Italy - July 29, 2021 - Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, today announced half-year results for the period ended 30 June 2021. 
Key Highlights
During the first half of 2021, activities were focused on the preparations for the US commercial launch of Winlevi(R) (clascoterone cream 1 %) and advancing the development of clascoterone solution for androgenetic alopecia (AGA). ....

United States , United Kingdom , City Of , Sun Pharma , Pierpaolo Guzzo , Luigi Moro , Marco Lecchi , Diana Harbort , Alessandro Mazzetti , Sun Pharmaceuticals Industries Ltd , Cosmo Pharmaceuticals , Jefferies Global Health Care Conference , Sun Pharmaceutical Industries Ltd , Half Year , Sun Pharmaceuticals Industries , Supply Agreements , Patient Reported Outcome , Cassiopea Spa , Sun Pharmaceutical Industries , Half Year Ended June , Active Principle Ingredient , Finance Director , Half Year Report , Safety Information , Investor Relations , ஒன்றுபட்டது மாநிலங்களில் ,

Cosmo Pharmaceuticals Announces Cassiopea SpA's Signing of License and Supply Agreements for Winlevi® in US and Canada


Search jobs
26-Jul-2021
Cosmo Pharmaceuticals Announces Cassiopea SpA’s Signing of License and Supply Agreements for Winlevi® in US and Canada
Cosmo Pharmaceuticals N.V. / Key word(s): Agreement/Alliance
26-Jul-2021 / 06:01 GMT/BST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Ad hoc announcement pursuant to Art. 53 LR
Dublin, Ireland - 26 July 2021: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) announced today that Cassiopea SpA (SIX: SKIN), a company in which it holds 46.56% of the ordinary shares, has signed license and supply agreements with Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharma ) for Winlevi ....

United States , Sun Pharma , Falk Gmbh , Niall Donnelly , Cosmo Pharmaceuticals , Credit Suisse Swiss Equity Forum Switzerland , Sun Pharmaceutical Industries Ltd , United States Food Drug Administration , Cosmo Pharmaceuticalsnv Key , Agreement Alliance , Redhill Biopharma Ltd , Cassiopea Spa , Sun Pharmaceutical Industries , Sun Pharma , United States Food , Drug Administration , Suisse Swiss Equity Forum Switzerland , Redhill Biopharma , ஒன்றுபட்டது மாநிலங்களில் , சூரியன் பார்மா , ஃபாக் கஂப் , நியால் டோநிலீ , பிரபஞ்சம் மருந்துகள் , சூரியன் மருந்து தொழில்கள் லிமிடெட் , சூரியன் மருந்து தொழில்கள் , ஒன்றுபட்டது மாநிலங்களில் உணவு ,